Liv Pure Peptide Product: Cjc-1295 + NO DAC

Liv Pure Peptides Cjc-1295 + NO DAC (GRF1‑29) Categories: Hormone Optimization, Fitness & Performance, Anti Aging $45.00 CAS# 863288-34-0 Formula: C152H255N44O42 Molecular Weight: 3367.940 g/mol

Modified GRF (CJC-1295 No DAC) is a truncated peptide analog of growth hormone-releasing hormone (GHRH) designed for scientific exploration of endocrine modulation and tissue regeneration. Research investigations have demonstrated its potential to enhance muscle repair and growth, accelerate wound healing, and support bone strength, while also promoting lipolysis and improved metabolic function. Additionally, exploratory studies indicate potential roles in blood sugar regulation and immune system modulation.

For Research Use Only – Not for Human Consumption.

Out of Stock

Sizes

5 mg

Liv Pure Peptides Products: Cjc-1295 + NO DAC 5mg

At Liv Pure Peptides, innovation meets purity. Our advanced research and rigorous quality standards deliver breakthrough peptide solutions for better health and science.

Shop Products

Products

Pages

Legal

Newsletter Signup

YOU MUST BE OVER 21 YEARS OLD TO USE THIS WEBSITE.

All products provided by Liv Pure are intended solely for in‑vitro laboratory research purposes. These materials are expressly forbidden for any form of human or animal use, ingestion, or administration, and all products are sold strictly for research, laboratory, or analytical purposes – not for human consumption.

The products offered on this platform are not formulated, designed, or intended to diagnose, cure, mitigate, treat, or prevent any diseases or medical conditions. Additionally, these statements have not been evaluated by the Food and Drug Administration, and our products are not intended to diagnose, treat, cure, or prevent any disease.

All products are for Research and Development use only and are not for human consumption.

Liv Pure is a chemical supplier; LIV Pure Peptides is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor is it an outsourcing facility as defined under Section 503B of the Act.